CN103664536A - Synthetic method of hydroxytyrosol - Google Patents
Synthetic method of hydroxytyrosol Download PDFInfo
- Publication number
- CN103664536A CN103664536A CN201210342015.7A CN201210342015A CN103664536A CN 103664536 A CN103664536 A CN 103664536A CN 201210342015 A CN201210342015 A CN 201210342015A CN 103664536 A CN103664536 A CN 103664536A
- Authority
- CN
- China
- Prior art keywords
- methylene
- dioxy
- hydroxytyrosol
- reaction
- methylenedioxy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- JUUBCHWRXWPFFH-UHFFFAOYSA-N Hydroxytyrosol Chemical compound OCCC1=CC=C(O)C(O)=C1 JUUBCHWRXWPFFH-UHFFFAOYSA-N 0.000 title claims abstract description 74
- 235000003248 hydroxytyrosol Nutrition 0.000 title claims abstract description 35
- 229940095066 hydroxytyrosol Drugs 0.000 title claims abstract description 35
- 238000010189 synthetic method Methods 0.000 title claims abstract description 7
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims abstract description 34
- 238000006243 chemical reaction Methods 0.000 claims abstract description 28
- YCIMNLLNPGFGHC-UHFFFAOYSA-N catechol Chemical compound OC1=CC=CC=C1O YCIMNLLNPGFGHC-UHFFFAOYSA-N 0.000 claims abstract description 22
- -1 3,4-methylenedioxy phenylglyoxylic acid ester Chemical class 0.000 claims abstract description 17
- JADSGOFBFPTCHG-UHFFFAOYSA-N 2-(1,3-benzodioxol-5-yl)ethanol Chemical compound OCCC1=CC=C2OCOC2=C1 JADSGOFBFPTCHG-UHFFFAOYSA-N 0.000 claims abstract description 14
- CTSLXHKWHWQRSH-UHFFFAOYSA-N oxalyl chloride Chemical compound ClC(=O)C(Cl)=O CTSLXHKWHWQRSH-UHFFFAOYSA-N 0.000 claims abstract description 14
- FTNJQNQLEGKTGD-UHFFFAOYSA-N 1,3-benzodioxole Chemical compound C1=CC=C2OCOC2=C1 FTNJQNQLEGKTGD-UHFFFAOYSA-N 0.000 claims abstract description 12
- ILAHWRKJUDSMFH-UHFFFAOYSA-N boron tribromide Chemical compound BrB(Br)Br ILAHWRKJUDSMFH-UHFFFAOYSA-N 0.000 claims abstract description 10
- 239000012280 lithium aluminium hydride Substances 0.000 claims abstract description 6
- 239000012448 Lithium borohydride Substances 0.000 claims abstract description 5
- 239000012279 sodium borohydride Substances 0.000 claims abstract description 5
- 229910000033 sodium borohydride Inorganic materials 0.000 claims abstract description 5
- 238000006722 reduction reaction Methods 0.000 claims abstract description 4
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims abstract description 3
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 claims abstract description 3
- 239000000126 substance Substances 0.000 claims abstract 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims description 15
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 15
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 13
- 238000000034 method Methods 0.000 claims description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 11
- 238000002360 preparation method Methods 0.000 claims description 10
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims description 9
- JRMUNVKIHCOMHV-UHFFFAOYSA-M tetrabutylammonium bromide Chemical compound [Br-].CCCC[N+](CCCC)(CCCC)CCCC JRMUNVKIHCOMHV-UHFFFAOYSA-M 0.000 claims description 7
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 claims description 6
- UKVIEHSSVKSQBA-UHFFFAOYSA-N methane;palladium Chemical compound C.[Pd] UKVIEHSSVKSQBA-UHFFFAOYSA-N 0.000 claims description 5
- 238000010992 reflux Methods 0.000 claims description 5
- 238000003756 stirring Methods 0.000 claims description 5
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 4
- 239000002994 raw material Substances 0.000 claims description 4
- NWZSZGALRFJKBT-KNIFDHDWSA-N (2s)-2,6-diaminohexanoic acid;(2s)-2-hydroxybutanedioic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O.NCCCC[C@H](N)C(O)=O NWZSZGALRFJKBT-KNIFDHDWSA-N 0.000 claims description 3
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 3
- 238000010438 heat treatment Methods 0.000 claims description 3
- IKDUDTNKRLTJSI-UHFFFAOYSA-N hydrazine monohydrate Substances O.NN IKDUDTNKRLTJSI-UHFFFAOYSA-N 0.000 claims description 3
- 238000005727 Friedel-Crafts reaction Methods 0.000 claims description 2
- 239000003444 phase transfer catalyst Substances 0.000 claims description 2
- 238000001953 recrystallisation Methods 0.000 claims description 2
- 239000002253 acid Substances 0.000 claims 4
- 150000005529 1,3-benzodioxoles Chemical class 0.000 claims 3
- 239000003513 alkali Substances 0.000 claims 2
- 229960001760 dimethyl sulfoxide Drugs 0.000 claims 2
- HZVOZRGWRWCICA-UHFFFAOYSA-N methanediyl Chemical compound [CH2] HZVOZRGWRWCICA-UHFFFAOYSA-N 0.000 claims 2
- JBVNWTXRFKZNBQ-UHFFFAOYSA-N 5-(1,3-benzodioxol-5-yl)-3-hexylcyclohex-2-en-1-one Chemical compound C1C(CCCCCC)=CC(=O)CC1C1=CC=C(OCO2)C2=C1 JBVNWTXRFKZNBQ-UHFFFAOYSA-N 0.000 claims 1
- 238000006856 Wolf-Kishner-Huang Minlon reduction reaction Methods 0.000 claims 1
- 238000004821 distillation Methods 0.000 claims 1
- 229910052500 inorganic mineral Inorganic materials 0.000 claims 1
- 239000011707 mineral Substances 0.000 claims 1
- FAQJJMHZNSSFSM-UHFFFAOYSA-N phenylglyoxylic acid Chemical class OC(=O)C(=O)C1=CC=CC=C1 FAQJJMHZNSSFSM-UHFFFAOYSA-N 0.000 claims 1
- 239000000725 suspension Substances 0.000 claims 1
- 230000002459 sustained effect Effects 0.000 claims 1
- ODVLMCWNGKLROU-UHFFFAOYSA-N 2-(1,3-benzodioxol-5-yl)acetic acid Chemical compound OC(=O)CC1=CC=C2OCOC2=C1 ODVLMCWNGKLROU-UHFFFAOYSA-N 0.000 abstract description 10
- 238000003786 synthesis reaction Methods 0.000 abstract description 4
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 abstract description 3
- 230000015572 biosynthetic process Effects 0.000 abstract description 2
- 239000003814 drug Substances 0.000 abstract description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 abstract 2
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 abstract 2
- 229910052763 palladium Inorganic materials 0.000 abstract 1
- 239000012070 reactive reagent Substances 0.000 abstract 1
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 12
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 8
- 239000000243 solution Substances 0.000 description 8
- 238000004458 analytical method Methods 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 238000005160 1H NMR spectroscopy Methods 0.000 description 5
- 239000003208 petroleum Substances 0.000 description 4
- 238000000425 proton nuclear magnetic resonance spectrum Methods 0.000 description 4
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 239000012074 organic phase Substances 0.000 description 3
- YCCILVSKPBXVIP-UHFFFAOYSA-N 2-(4-hydroxyphenyl)ethanol Chemical compound OCCC1=CC=C(O)C=C1 YCCILVSKPBXVIP-UHFFFAOYSA-N 0.000 description 2
- CFFZDZCDUFSOFZ-UHFFFAOYSA-N 3,4-Dihydroxy-phenylacetic acid Chemical compound OC(=O)CC1=CC=C(O)C(O)=C1 CFFZDZCDUFSOFZ-UHFFFAOYSA-N 0.000 description 2
- RFWGABANNQMHMZ-UHFFFAOYSA-N 8-acetoxy-7-acetyl-6,7,7a,8-tetrahydro-5H-benzo[g][1,3]dioxolo[4',5':4,5]benzo[1,2,3-de]quinoline Natural products CC=C1C(CC(=O)OCCC=2C=C(O)C(O)=CC=2)C(C(=O)OC)=COC1OC1OC(CO)C(O)C(O)C1O RFWGABANNQMHMZ-UHFFFAOYSA-N 0.000 description 2
- HKVGJQVJNQRJPO-UHFFFAOYSA-N Demethyloleuropein Natural products O1C=C(C(O)=O)C(CC(=O)OCCC=2C=C(O)C(O)=CC=2)C(=CC)C1OC1OC(CO)C(O)C(O)C1O HKVGJQVJNQRJPO-UHFFFAOYSA-N 0.000 description 2
- 238000005481 NMR spectroscopy Methods 0.000 description 2
- RFWGABANNQMHMZ-HYYSZPHDSA-N Oleuropein Chemical compound O([C@@H]1OC=C([C@H](C1=CC)CC(=O)OCCC=1C=C(O)C(O)=CC=1)C(=O)OC)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O RFWGABANNQMHMZ-HYYSZPHDSA-N 0.000 description 2
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 2
- 230000001093 anti-cancer Effects 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 238000004440 column chromatography Methods 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 150000007529 inorganic bases Chemical class 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- 235000011576 oleuropein Nutrition 0.000 description 2
- RFWGABANNQMHMZ-CARRXEGNSA-N oleuropein Natural products COC(=O)C1=CO[C@@H](O[C@H]2O[C@@H](CO)[C@H](O)[C@@H](O)[C@@H]2O)C(=CC)[C@H]1CC(=O)OCCc3ccc(O)c(O)c3 RFWGABANNQMHMZ-CARRXEGNSA-N 0.000 description 2
- 239000004006 olive oil Substances 0.000 description 2
- 235000008390 olive oil Nutrition 0.000 description 2
- 230000008092 positive effect Effects 0.000 description 2
- 238000001308 synthesis method Methods 0.000 description 2
- 230000002194 synthesizing effect Effects 0.000 description 2
- 239000002351 wastewater Substances 0.000 description 2
- BMHMKWXYXFBWMI-UHFFFAOYSA-N 3,4-Methylenedioxyacetophenone Chemical compound CC(=O)C1=CC=C2OCOC2=C1 BMHMKWXYXFBWMI-UHFFFAOYSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical compound [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- DBLDQZASZZMNSL-QMMMGPOBSA-N L-tyrosinol Natural products OC[C@@H](N)CC1=CC=C(O)C=C1 DBLDQZASZZMNSL-QMMMGPOBSA-N 0.000 description 1
- 241000207836 Olea <angiosperm> Species 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- VEFXTGTZJOWDOF-UHFFFAOYSA-N benzene;hydrate Chemical compound O.C1=CC=CC=C1 VEFXTGTZJOWDOF-UHFFFAOYSA-N 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 229910052796 boron Inorganic materials 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- USLKCMBGQFYUFI-UHFFFAOYSA-N dichloromethane;tribromoborane Chemical compound ClCCl.BrB(Br)Br USLKCMBGQFYUFI-UHFFFAOYSA-N 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- OWZFULPEVHKEKS-UHFFFAOYSA-N ethyl 2-chloro-2-oxoacetate Chemical compound CCOC(=O)C(Cl)=O OWZFULPEVHKEKS-UHFFFAOYSA-N 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 239000012065 filter cake Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 125000000896 monocarboxylic acid group Chemical group 0.000 description 1
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 230000000391 smoking effect Effects 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000000967 suction filtration Methods 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 235000004330 tyrosol Nutrition 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C37/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring
- C07C37/01—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring by replacing functional groups bound to a six-membered aromatic ring by hydroxy groups, e.g. by hydrolysis
- C07C37/055—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring by replacing functional groups bound to a six-membered aromatic ring by hydroxy groups, e.g. by hydrolysis the substituted group being bound to oxygen, e.g. ether group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
- C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
- C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
- C07D317/54—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
- C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
- C07D317/60—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Description
技术领域 technical field
本发明属于药物合成技术领域,具体涉及一种羟基酪醇的化学合成方法。The invention belongs to the technical field of drug synthesis, and in particular relates to a chemical synthesis method of hydroxytyrosol.
背景技术 Background technique
羟基酪醇(hydroxytyrosol)又名3,4二羟基苯乙醇,它主要是以酯化物橄榄苦苷的形式存在于橄榄的各个部位,橄榄苦苷经过水解后可得到游离的羟基酪醇。是一种天然的多酚类化合物,具有很强的抗氧化性。近年来,国内外大量研究证实羟基酪醇具有很多有益于人体健康的生物药理活性(1)羟基酪醇在降低血压,预防心血管疾病方面有积极的促进作用;(2)羟基酪醇对骨骼生长发育及机能有益处;(3)羟基酪醇在抗癌防癌方面也有应用;(4)羟基酪醇有抑菌作用;(5)羟基酪醇可以有效降低和抑制吸烟对人体的危害。由于其卓越的生理活性,近年来深受生物和医学界的重视。Hydroxytyrosol, also known as 3,4 dihydroxyphenylethanol, mainly exists in various parts of olives in the form of esterified oleuropein, and free hydroxytyrosol can be obtained after oleuropein is hydrolyzed. It is a natural polyphenolic compound with strong antioxidant properties. In recent years, a large number of studies at home and abroad have confirmed that hydroxytyrosol has many biopharmacological activities beneficial to human health (1) hydroxytyrosol has a positive effect on lowering blood pressure and preventing cardiovascular diseases; (2) hydroxytyrosol has a positive effect on bone (3) Hydroxytyrosol is also used in anti-cancer and anti-cancer; (4) Hydroxytyrosol has antibacterial effect; (5) Hydroxytyrosol can effectively reduce and inhibit the harm of smoking to the human body. Due to its excellent physiological activity, it has been valued by the biological and medical circles in recent years.
目前羟基酪醇主要由以下方式获得:(1)从榨橄榄油所产生的废水中提取羟基酪醇。这种方法的优点是对生产橄榄油所产生的废水进行废物利用,减少对环境的污染。但此方法需消耗大量溶剂,且羟基酪醇收率较低,不太适合工业化生产;(2)利用生物发酵法得到羟基酪醇。该方法涉及基因工程菌,技术要求比较高,生产周期长,目前技术还不成熟;(3)利用化学合成的方法制备羟基酪醇。近年来文献报道的羟基酪醇的人工合成方法主要是通过还原3,4-二羟基苯乙酸或氧化酪醇来制备。但以上路线原料稳定性较差,成本较高。帝斯曼公司还以邻苯二酚为原料,申请了制备羟基酪醇的方法专利,但路线中用到钯碳等昂贵的化学试剂,因此需要研究一种更加经济的合成羟基酪醇的方法。At present, hydroxytyrosol is mainly obtained by the following methods: (1) extracting hydroxytyrosol from waste water produced by pressing olive oil. The advantage of this method is that the waste water produced in the production of olive oil is used to reduce the pollution to the environment. However, this method needs to consume a large amount of solvent, and the yield of hydroxytyrosol is low, so it is not suitable for industrial production; (2) obtain hydroxytyrosol by biological fermentation. The method involves genetically engineered bacteria, which has relatively high technical requirements and a long production period, and the current technology is immature; (3) the method of chemical synthesis is used to prepare hydroxytyrosol. The artificial synthesis method of hydroxytyrosol reported in the literature in recent years is mainly prepared by reducing 3,4-dihydroxyphenylacetic acid or oxidizing tyrosol. But the raw material stability of above route is poor, and cost is higher. DSM has also applied for a patent on the method for preparing hydroxytyrosol using catechol as a raw material, but expensive chemical reagents such as palladium carbon are used in the route, so it is necessary to study a more economical method for synthesizing hydroxytyrosol .
发明内容 Contents of the invention
本发明目的是提供一种更加经济羟基酪醇的合成方法,在保证与其它已公布的方法总体产率不变的同时,大大降低了合成羟基酪醇的成本。The purpose of the present invention is to provide a more economical synthesis method of hydroxytyrosol, which greatly reduces the cost of synthesizing hydroxytyrosol while keeping the overall yield unchanged from other published methods.
为达到上述目的,本发明采用的技术方案是:一种羟基酪醇的合成方法,包括以下步骤:In order to achieve the above object, the technical scheme adopted in the present invention is: a kind of synthetic method of hydroxytyrosol, comprises the following steps:
(1)用二氯甲烷保护邻苯二酚的两个酚羟基:邻苯二酚与二氯甲烷反应制备1,2-亚甲二氧基苯;(1) protect two phenolic hydroxyl groups of catechol with dichloromethane: react catechol with dichloromethane to prepare 1,2-methylenedioxybenzene;
(2)以结构通式a所示的草酰氯的各种单酯为傅克反应的原料,与1,2-亚甲二氧基苯反应制备3,4-亚甲二氧基苯乙酮酸酯,a中的R为C1-C6的烷基或C6H5CH2。(2) With the various monoesters of oxalyl chloride shown in general structural formula a as the raw material of Friedel-Crafts reaction, prepare 3,4-methylenedioxyacetophenone by reacting with 1,2-methylenedioxybenzene ester, R in a is C 1 -C 6 alkyl or C 6 H 5 CH 2 .
(3)3,4-亚甲二氧基苯乙酮酸酯通过Wolff-Kishner-黄鸣龙还原反应制备3,4-亚甲二氧基苯乙酸;(3) 3,4-methylenedioxyacetophenone ester is prepared by Wolff-Kishner-Huang Minglong reduction reaction to prepare 3,4-methylenedioxyphenylacetic acid;
(4)使用氢化锂铝或硼氢化锂或硼氢化钠还原3,4-亚甲二氧基苯乙酸制备3,4-亚甲二氧基苯乙醇,然后用三溴化硼或钯碳脱掉3,4-亚甲二氧基苯乙醇的亚甲基保护制备羟基酪醇。(4) Use lithium aluminum hydride or lithium borohydride or sodium borohydride to reduce 3,4-methylenedioxyphenylacetic acid to prepare 3,4-methylenedioxyphenethyl alcohol, and then use boron tribromide or palladium carbon to desorb Preparation of hydroxytyrosol by removing the methylene protection of 3,4-methylenedioxyphenethyl alcohol.
具体的一种羟基酪醇的制备方法包括以下步骤:A specific preparation method of hydroxytyrosol comprises the following steps:
(1)将四丁基溴化铵(TBAB)溶于二甲基亚砜,加热至110℃回流,向其中同时滴加邻苯二酚的二甲基亚砜溶液,以及50%的无机碱溶液,持续反应结束后,加水,继续加热蒸馏,收集99~104℃馏分,将馏出液处理得1,2-亚甲二氧基苯;(1) Dissolve tetrabutylammonium bromide (TBAB) in dimethyl sulfoxide, heat to reflux at 110°C, and simultaneously add catechol dimethyl sulfoxide solution and 50% inorganic base dropwise Solution, after the continuous reaction, add water, continue heating and distilling, collect fractions at 99-104°C, and treat the distillate to obtain 1,2-methylenedioxybenzene;
其中,所述无机碱为氢氧化钠或氢氧化钾,相转移催化剂TBAB与邻苯二酚的摩尔比为0.05~0.1∶1;Wherein, the inorganic base is sodium hydroxide or potassium hydroxide, and the molar ratio of the phase transfer catalyst TBAB to catechol is 0.05~0.1:1;
(2)将三氯化铝加入无水二氯甲烷中,搅拌至悬浮。在冰浴条件下向其中滴加草酰氯单酯,待充分搅拌后,再向体系中滴加胡椒环,室温条件反应结束后,加水淬灭反应,分离提纯,得到3,4-亚甲二氧基苯乙酮酸酯;(2) Add aluminum trichloride to anhydrous dichloromethane and stir until suspended. Add dropwise oxalyl chloride monoester to it under ice bath condition, after fully stirring, add piperonylcycline dropwise to the system, after the reaction at room temperature, add water to quench the reaction, separate and purify to obtain 3,4-methylene di Oxyacetophenone ester;
其中,所述1,2-亚甲二氧基苯、无水三氯化铝及草酰氯单酯的摩尔比为1∶1.15∶1.05~1.15;Wherein, the molar ratio of the 1,2-methylenedioxybenzene, anhydrous aluminum trichloride and oxalyl chloride monoester is 1:1.15:1.05~1.15;
(3)将3,4-亚甲二氧基苯乙酮酸酯与水合肼溶于乙二醇,缓慢升温,加热回流,反应结束后,冷却至室温后加入研磨好的氢氧化钾,加热,边升温边蒸出低沸物,结束后,再回流反应几个小时,冷却至室温,滴加稀盐酸溶液调pH至2~3,初步后处理,以乙酸乙酯-石油醚体系重结晶,得到3,4-亚甲二氧基苯乙酸;(3) Dissolve 3,4-methylenedioxyacetophenone ester and hydrazine hydrate in ethylene glycol, slowly heat up, heat to reflux, after the reaction is over, cool to room temperature, add ground potassium hydroxide, heat , evaporate low boilers while raising the temperature, after the end, reflux for a few hours, cool to room temperature, drop dilute hydrochloric acid solution to adjust the pH to 2-3, preliminary post-treatment, recrystallization with ethyl acetate-petroleum ether system , to obtain 3,4-methylenedioxyphenylacetic acid;
(4)按照现有技术,使用氢化锂铝或硼氢化锂或硼氢化钠还原3,4-亚甲二氧基苯乙酸制备3,4-亚甲二氧基苯乙醇,然后用三溴化硼或钯碳脱掉3,4-亚甲二氧基苯乙醇的亚甲基保护制备羟基酪醇。(4) According to the prior art, use lithium aluminum hydride or lithium borohydride or sodium borohydride to reduce 3,4-methylenedioxyphenylacetic acid to prepare 3,4-methylenedioxyphenylethyl alcohol, and then use tribrominated The methylene protection of 3,4-methylenedioxyphenethyl alcohol was removed by boron or palladium carbon to prepare hydroxytyrosol.
本发明与现有技术相比具有如下优点和效果:Compared with the prior art, the present invention has the following advantages and effects:
本发明使用的反应试剂易得,廉价,反应条件温和,整个反应的最终产率为23%,反应成本大大降低,有良好的工业化应用前景。The reaction reagent used in the invention is easy to obtain, cheap, mild reaction conditions, the final yield of the whole reaction is 23%, the reaction cost is greatly reduced, and has good industrial application prospect.
附图说明 Description of drawings
图1为实施例一中制备羟基酪醇的合成路线示意图;Fig. 1 is the synthetic route schematic diagram of preparing hydroxytyrosol in embodiment one;
图2为实施例一中1,2-亚甲二氧基苯的核磁共振氢谱分析图;Fig. 2 is the proton nuclear magnetic resonance spectrum analysis figure of 1,2-methylenedioxybenzene in embodiment one;
图3为实施例一中3,4-亚甲二氧基苯乙酮酸乙酯的核磁共振氢谱分析图;Fig. 3 is the proton nuclear magnetic resonance spectrum analysis figure of 3,4-methylenedioxyacetophenone ethyl ester in embodiment one;
图4为实施例一中3,4-亚甲二氧基苯乙酸的核磁共振氢谱分析图;Fig. 4 is the proton nuclear magnetic resonance spectrum analysis figure of 3,4-methylenedioxyphenylacetic acid in embodiment one;
图5为实施例一中3,4-亚甲二氧基苯乙醇的核磁共振氢谱分析图;Fig. 5 is the proton nuclear magnetic resonance spectrum analysis figure of 3,4-methylenedioxyphenethyl alcohol in embodiment one;
图6为实施例一中羟基酪醇的核磁共振氢谱分析图。Fig. 6 is the H NMR spectrum analysis diagram of hydroxytyrosol in Example 1.
具体实施方式 Detailed ways
下面结合附图及实施例对本发明做进一步描述:The present invention will be further described below in conjunction with accompanying drawing and embodiment:
实施例一:根据图1所示合成路线合成羟基酪醇Embodiment one: Synthetic hydroxytyrosol according to the synthetic route shown in Figure 1
1、制备1,2-亚甲二氧基苯(3)1. Preparation of 1,2-methylenedioxybenzene (3)
250ml三口瓶中加入DMSO(80ml),二氯甲烷(20ml),TBAB(1.9g,6mmol),缓慢升温至110℃,略见回流时,向反应器内缓慢滴加溶有邻苯二酚(11g,0.1mol)的DMSO(60mL)溶液,同时滴加50%的氢氧化钠水溶液(氢氧化钠8g,0.2mol,水8mL),约2h滴加完毕,再持续反应约1h,TLC监测反应结束。Add DMSO (80ml), dichloromethane (20ml), and TBAB (1.9g, 6mmol) to a 250ml three-necked flask, and slowly heat up to 110°C. When reflux is seen, slowly add catechol ( 11g, 0.1mol) of DMSO (60mL) solution, add dropwise 50% sodium hydroxide aqueous solution (sodium hydroxide 8g, 0.2mol, water 8mL) at the same time, add dropwise for about 2h, continue to react for about 1h, and monitor the reaction by TLC Finish.
向反应瓶中加入100mL水,继续加热,收集99-104℃的馏分。此馏分为水和1,2-亚甲二氧基苯的共沸物,呈白色浑浊状,当馏出物澄清后,则已不含有1,2-亚甲二氧基苯。将馏出液进行处理得无色透明状液体(9.97g,81.7%)。Add 100mL of water to the reaction flask, continue heating, and collect the fraction at 99-104°C. This distillate is an azeotrope of water and 1,2-methylenedioxybenzene, which is white and turbid. When the distillate is clear, it does not contain 1,2-methylenedioxybenzene. The distillate was treated to obtain a colorless transparent liquid (9.97 g, 81.7%).
进行核磁分析,得图2,结果如下:Carry out NMR analysis, get Fig. 2, the result is as follows:
1H-NMR(CDCl3):δ/ppm 5.97(2H,s,CH 2 ),6.87(4H,s,ArH). 1 H-NMR (CDCl 3 ): δ/ppm 5.97 (2H, s, CH 2 ), 6.87 (4H, s, Ar H ).
以上结果表明,所得产物为1,2-亚甲二氧基苯。The above results show that the obtained product is 1,2-methylenedioxybenzene.
2、制备3,4-亚甲二氧基苯乙酮酸乙酯(4)2. Preparation of ethyl 3,4-methylenedioxyacetophenone (4)
250ml三口瓶中加入无水二氯甲烷(60mL),三氯化铝(5.85g,0.043mol),搅拌至悬浮。缓慢滴加草酰氯单乙酯(5.88g,0.043mol),约30min内滴加完毕,室温搅拌10min,溶液呈淡黄色。冰浴下逐滴加入3(5g,0.041mol),约10min滴加完毕,撤去冰浴,室温反应1h,TLC监测反应结束。Add anhydrous dichloromethane (60 mL) and aluminum trichloride (5.85 g, 0.043 mol) into a 250 ml three-necked flask, and stir until suspended. Monoethyl oxalyl chloride (5.88 g, 0.043 mol) was slowly added dropwise, and the addition was completed within about 30 min. Stir at room temperature for 10 min, and the solution turned pale yellow. 3 (5 g, 0.041 mol) was added dropwise in an ice bath, and the dropwise addition was completed in about 10 minutes. The ice bath was removed, and the reaction was carried out at room temperature for 1 hour, and the reaction was monitored by TLC.
冰浴下缓慢加入3倍当量的水,用乙酸乙酯萃取三次,合并有机相,有机相依次经5%碳酸氢钠水溶液(30ml×2)和水(40ml×2)洗涤,无水硫酸钠干燥后过滤,滤液减压浓缩,得到的产物用柱层析分离,[V(石油醚)∶V(乙酸乙酯)=40∶1]得到淡黄色油状物(6.5g,72.3%)。Slowly add 3 times the equivalent of water under ice bath, extract three times with ethyl acetate, combine the organic phases, and wash the organic phases successively with 5% aqueous sodium bicarbonate solution (30ml×2) and water (40ml×2), anhydrous sodium sulfate After drying and filtering, the filtrate was concentrated under reduced pressure, and the obtained product was separated by column chromatography [V (petroleum ether): V (ethyl acetate) = 40: 1] to obtain a light yellow oil (6.5 g, 72.3%).
进行核磁分析,得图3,结果如下:Carry out NMR analysis, get Fig. 3, the result is as follows:
1H-NMR(CDCl3):δ/ppm 1.41-1.45(3H,t,CH2 CH 3 ),4.42-4.47(2H,m,CH 2 CH3),6.10(2H,s,CH 2 ),6.90-6.92(1H,d,ArH),7.49-7.50(1H,d,ArH),7.62-7.64(1H,dd,ArH). 1 H-NMR (CDCl 3 ): δ/ppm 1.41-1.45 (3H, t, CH 2 CH 3 ), 4.42-4.47 (2H, m, CH 2 CH 3 ), 6.10 (2H, s, CH 2 ), 6.90-6.92 (1H, d, Ar H ), 7.49-7.50 (1H, d, Ar H ), 7.62-7.64 (1H, dd, Ar H ).
以上结果表明,所得产物为3,4-亚甲二氧基苯乙酮酸乙酯。The above results show that the obtained product is ethyl 3,4-methylenedioxyacetophenone.
3、制备3,4-亚甲二氧基苯乙酸(5)3. Preparation of 3,4-methylenedioxyphenylacetic acid (5)
250ml三颈瓶中加入4(6.7g,0.03mol)、乙二醇(60ml)和85%水合肼(8.85g,0.15mol),缓慢升温至120℃反应2h。冷却至室温后加入氢氧化钾(5g,0.09mol),加热至180℃,边升温边蒸出低沸物(约2h),再回流反应4h。反应结束后冷却至室温,加6mol/L盐酸调至pH 2~3。加入水(60ml),用乙酸乙酯萃取(50ml×4),合并有机相。用水洗涤(50ml×2)后,经无水硫酸钠干燥后抽滤,滤液减压浓缩至干,剩余物用乙酸乙酯-石油醚(1∶1)重结晶,得白色固体(3.39g,62.8%)。Add 4 (6.7g, 0.03mol), ethylene glycol (60ml) and 85% hydrazine hydrate (8.85g, 0.15mol) into a 250ml three-necked flask, and slowly raise the temperature to 120°C for 2h. After cooling to room temperature, potassium hydroxide (5 g, 0.09 mol) was added, heated to 180° C., low boilers were evaporated (about 2 h) while the temperature was raised, and then refluxed for 4 h. Cool to room temperature after the reaction, add 6mol/L hydrochloric acid to adjust the pH to 2-3. Water (60ml) was added, extracted with ethyl acetate (50ml×4), and the organic phases were combined. After washing with water (50ml×2), drying over anhydrous sodium sulfate and suction filtration, the filtrate was concentrated to dryness under reduced pressure, and the residue was recrystallized with ethyl acetate-petroleum ether (1:1) to obtain a white solid (3.39g, 62.8%).
进行核磁分析,得图4,结果如下:Carry out nuclear magnetic analysis, get Fig. 4, the result is as follows:
1H-NMR(CDCl3):δ/ppm 3.59(2H,s,CH 2 COOH),5.97(2H,s,CH 2 ),6.73-6.75(1H,dd,ArH),6.78(1H,s,ArH),6.80-6.81(1H,d,ArH). 1 H-NMR (CDCl3): δ/ppm 3.59 (2H, s, CH 2 COOH), 5.97 (2H, s, CH 2 ), 6.73-6.75 (1H, dd, Ar H ), 6.78 (1H, s, Ar H ), 6.80-6.81 (1H, d, Ar H ).
以上结果表明,所得产物为3,4-亚甲二氧基苯乙酸。The above results show that the product obtained is 3,4-methylenedioxyphenylacetic acid.
4、制备3,4-亚甲二氧基苯乙醇(6)4. Preparation of 3,4-methylenedioxyphenethyl alcohol (6)
100ml三口瓶中加入5(3g,0.017mol),无水四氢呋喃(30mL),置于冰浴条件下混匀。小心加入氢化铝锂铝(1.7g,0.05mol),回流反应4h,TLC监测反应结束。Add 5 (3 g, 0.017 mol) and anhydrous tetrahydrofuran (30 mL) into a 100 ml three-necked flask, and mix well under ice bath conditions. Lithium aluminum hydride (1.7 g, 0.05 mol) was added carefully, the reaction was refluxed for 4 h, and the reaction was completed by TLC monitoring.
冰浴条件下,缓慢加入3倍当量的NaOH溶液(1mol/L),3倍当量的水。过滤,用二氯甲烷洗涤滤饼,浓缩,拌样上硅胶柱,石油醚∶乙酸乙酯=3∶1得到略显黄色的透明油状物(2.28g,81%)。Under the condition of ice bath, slowly add 3 times equivalent of NaOH solution (1mol/L), 3 times of equivalent of water. Filter, wash the filter cake with dichloromethane, concentrate, mix the sample onto a silica gel column, petroleum ether: ethyl acetate = 3:1 to obtain a slightly yellow transparent oil (2.28g, 81%).
1H-NMR(CDCl3):δ/ppm 1.55(1H,s,CH2CH2 OH),2.79-2.82(2H,t,CH 2 CH2OH),3.82-3.85(2H,t,CH2 CH 2 OH),5.95(2H,s,CH 2 ),6.69-6.71(1H,dd,ArH),6.74-6.75(1H,d,ArH),6.77-6.79(1H,d,ArH). 1 H-NMR (CDCl 3 ): δ/ppm 1.55 (1H, s, CH 2 CH 2 OH ), 2.79-2.82 (2H, t, CH 2 CH 2 OH), 3.82-3.85 (2H, t, CH 2 CH 2 OH), 5.95 (2H, s, CH 2 ), 6.69-6.71 (1H, dd, ArH), 6.74-6.75 (1H, d, Ar H ), 6.77-6.79 (1H, d, Ar H ).
以上结果表明,所得产物为3,4-亚甲二氧基苯乙醇。The above results show that the resulting product is 3,4-methylenedioxyphenethyl alcohol.
5、制备羟基酪醇(1)5. Preparation of hydroxytyrosol (1)
50ml反应瓶中加入6(0.2g,1.20mmol),无水二氯甲烷(25ml),冷却至-40℃,用注射器滴加三溴化硼的二氯甲烷溶液(含三溴化硼1.78mol/L)4.3ml。滴加完毕,室温下反应2h,TLC检测反应结束。冰浴下滴加10ml甲醇淬灭反应,浓缩,残留液柱层析分离,得到羟基酪醇1,为白色粉末(0.141g,76%)。Add 6 (0.2g, 1.20mmol) and anhydrous dichloromethane (25ml) into a 50ml reaction flask, cool to -40°C, add boron tribromide dichloromethane solution dropwise with a syringe (containing boron tribromide 1.78mol /L) 4.3ml. After the dropwise addition was completed, the reaction was carried out at room temperature for 2 h, and the reaction was detected by TLC. The reaction was quenched by adding 10 ml of methanol dropwise in an ice bath, concentrated, and the residue was separated by liquid column chromatography to obtain
1H-NMR(CDCl3):δ/ppm 3.03-3.07(2H,t,CH 2 CH2OH),3.49-3.53(2H,t,CH2 CH 2 OH),5.04(1H,s,ArOH),5.14(1H,s,ArOH),6.64-6.66(1H,dd,ArH),6.73-6.74(1H,d,ArH),6.80-6.82(1H,d,ArH). 1 H-NMR (CDCl 3 ): δ/ppm 3.03-3.07 (2H, t, CH 2 CH 2 OH), 3.49-3.53 (2H, t, CH 2 CH 2 OH), 5.04 (1H, s, Ar OH ), 5.14 (1H, s, Ar OH ), 6.64-6.66 (1H, dd, Ar H ), 6.73-6.74 (1H, d, Ar H ), 6.80-6.82 (1H, d, Ar H ).
以上结果表明,所得产物为羟基酪醇。The above results show that the resulting product is hydroxytyrosol.
Claims (2)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210342015.7A CN103664536A (en) | 2012-09-17 | 2012-09-17 | Synthetic method of hydroxytyrosol |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210342015.7A CN103664536A (en) | 2012-09-17 | 2012-09-17 | Synthetic method of hydroxytyrosol |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN103664536A true CN103664536A (en) | 2014-03-26 |
Family
ID=50303433
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201210342015.7A Pending CN103664536A (en) | 2012-09-17 | 2012-09-17 | Synthetic method of hydroxytyrosol |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103664536A (en) |
Cited By (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104387240A (en) * | 2014-11-19 | 2015-03-04 | 陕西嘉禾植物化工有限责任公司 | Synthetic method of 2-(3,4-dihydroxyphenyl) ethanol |
| CN105837424A (en) * | 2016-03-31 | 2016-08-10 | 常州大学 | Synthetic method for 1-chloro-3-methyl-3-buten-2-one |
| CN106397387A (en) * | 2016-09-20 | 2017-02-15 | 苏州弘森药业股份有限公司 | Method for preparing pepper ring |
| CN106748770A (en) * | 2016-12-22 | 2017-05-31 | 山东海佑福瑞达制药有限公司 | A kind of simple and convenient process for preparing of felbinac |
| CN108164398A (en) * | 2018-01-26 | 2018-06-15 | 山东省药学科学院 | A kind of improved method of hydroxytyrosol synthesis technology |
| CN109438189A (en) * | 2018-11-02 | 2019-03-08 | 宁波申泰生物科技有限公司 | A kind of synthetic method of 3,4- dihydroxyphenyl ethanol |
| CN110563693A (en) * | 2019-09-30 | 2019-12-13 | 苏州弘森药业股份有限公司 | Preparation method of pepper ring |
| CN113264814A (en) * | 2021-06-10 | 2021-08-17 | 南京斯贝源医药科技有限公司 | Process for preparing hydroxytyrosol |
| DE102020132795A1 (en) | 2020-12-09 | 2022-06-09 | Technische Universität Bergakademie Freiberg, Körperschaft des öffentlichen Rechts | Process for the biotechnological production of 2-phenylethanols from plant sources |
| CN115057841A (en) * | 2022-03-24 | 2022-09-16 | 万华化学集团股份有限公司 | Method for preparing 1, 2-methylenedioxybenzene |
| CN120483875A (en) * | 2025-07-10 | 2025-08-15 | 营口市向阳催化剂有限责任公司 | Process for the preparation of substituted phenylene aromatic diesters and use thereof in the preparation of catalysts |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008107109A1 (en) * | 2007-03-07 | 2008-09-12 | Dsm Ip Assets B.V. | Process for the preparation of hydroxytyrosol |
| CN101891595A (en) * | 2010-07-22 | 2010-11-24 | 苏州大学 | A kind of preparation method of hydroxytyrosol |
| WO2012006783A1 (en) * | 2010-07-15 | 2012-01-19 | Lonza Ltd | Process for production of hydroxytyrosol using organometallic compounds |
| CN102617543A (en) * | 2012-03-13 | 2012-08-01 | 天津科技大学 | Synthesis methods for piperonyl ethanol and derivatives thereof |
-
2012
- 2012-09-17 CN CN201210342015.7A patent/CN103664536A/en active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008107109A1 (en) * | 2007-03-07 | 2008-09-12 | Dsm Ip Assets B.V. | Process for the preparation of hydroxytyrosol |
| WO2012006783A1 (en) * | 2010-07-15 | 2012-01-19 | Lonza Ltd | Process for production of hydroxytyrosol using organometallic compounds |
| CN101891595A (en) * | 2010-07-22 | 2010-11-24 | 苏州大学 | A kind of preparation method of hydroxytyrosol |
| CN102617543A (en) * | 2012-03-13 | 2012-08-01 | 天津科技大学 | Synthesis methods for piperonyl ethanol and derivatives thereof |
Non-Patent Citations (1)
| Title |
|---|
| 许超等,: "羟基酪醇合成工艺研究", 《精细化工》, vol. 27, no. 12, 2010, pages 1209 - 1212 * |
Cited By (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104387240B (en) * | 2014-11-19 | 2016-01-20 | 陕西嘉禾植物化工有限责任公司 | A kind of synthetic method of 2-(3,4-dihydroxy phenyl) ethanol |
| CN104387240A (en) * | 2014-11-19 | 2015-03-04 | 陕西嘉禾植物化工有限责任公司 | Synthetic method of 2-(3,4-dihydroxyphenyl) ethanol |
| CN105837424A (en) * | 2016-03-31 | 2016-08-10 | 常州大学 | Synthetic method for 1-chloro-3-methyl-3-buten-2-one |
| CN106397387A (en) * | 2016-09-20 | 2017-02-15 | 苏州弘森药业股份有限公司 | Method for preparing pepper ring |
| CN106748770A (en) * | 2016-12-22 | 2017-05-31 | 山东海佑福瑞达制药有限公司 | A kind of simple and convenient process for preparing of felbinac |
| CN106748770B (en) * | 2016-12-22 | 2019-09-17 | 山东海佑福瑞达制药有限公司 | A kind of simple and convenient process for preparing of felbinac |
| CN108164398A (en) * | 2018-01-26 | 2018-06-15 | 山东省药学科学院 | A kind of improved method of hydroxytyrosol synthesis technology |
| CN109438189B (en) * | 2018-11-02 | 2022-07-12 | 宁波申泰生物科技有限公司 | Synthetic method of 3, 4-dihydroxy phenethyl alcohol |
| CN109438189A (en) * | 2018-11-02 | 2019-03-08 | 宁波申泰生物科技有限公司 | A kind of synthetic method of 3,4- dihydroxyphenyl ethanol |
| CN110563693B (en) * | 2019-09-30 | 2022-10-21 | 苏州弘森药业股份有限公司 | Preparation method of pepper ring |
| CN110563693A (en) * | 2019-09-30 | 2019-12-13 | 苏州弘森药业股份有限公司 | Preparation method of pepper ring |
| DE102020132795A1 (en) | 2020-12-09 | 2022-06-09 | Technische Universität Bergakademie Freiberg, Körperschaft des öffentlichen Rechts | Process for the biotechnological production of 2-phenylethanols from plant sources |
| WO2022122921A1 (en) | 2020-12-09 | 2022-06-16 | Technische Universität Bergakademie Freiberg | Process for the biotechnological production of 2-phenylethanols from plant sources |
| DE102020132795B4 (en) | 2020-12-09 | 2025-02-13 | Technische Universität Bergakademie Freiberg, Körperschaft des öffentlichen Rechts | Process for the biotechnological production of 2-phenylethanols from plant sources |
| CN113264814A (en) * | 2021-06-10 | 2021-08-17 | 南京斯贝源医药科技有限公司 | Process for preparing hydroxytyrosol |
| CN113264814B (en) * | 2021-06-10 | 2022-07-26 | 南京斯贝源医药科技有限公司 | Process for preparing hydroxytyrosol |
| WO2022257519A1 (en) * | 2021-06-10 | 2022-12-15 | 南京斯贝源医药科技有限公司 | Process for preparing hydroxytyrosol |
| CN115057841A (en) * | 2022-03-24 | 2022-09-16 | 万华化学集团股份有限公司 | Method for preparing 1, 2-methylenedioxybenzene |
| CN115057841B (en) * | 2022-03-24 | 2023-09-19 | 万华化学集团股份有限公司 | Method for preparing 1, 2-methylenedioxybenzene |
| CN120483875A (en) * | 2025-07-10 | 2025-08-15 | 营口市向阳催化剂有限责任公司 | Process for the preparation of substituted phenylene aromatic diesters and use thereof in the preparation of catalysts |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103664536A (en) | Synthetic method of hydroxytyrosol | |
| CN102241651A (en) | Preparation method of azoxystrobin intermediate | |
| CN102659726B (en) | Method for synthesis of dronedarone | |
| CN103435556A (en) | Simple and quick method for synthesizing improved vitamin B1 intermediate 2-methyl-4-amino-5-aminomethylpyrimidine | |
| KR20130027568A (en) | Method for preparing rosuvastatin calcium intermediate | |
| CN106916060B (en) | Preparation method of high-purity p-hydroxyacetophenone | |
| CN106365986A (en) | Compounds and preparation methods thereof, and uses of compounds in synthesis of brivaracetam | |
| CN102267994B (en) | Preparation method of moxifloxacin hydrochloride known impurity | |
| CN103613498A (en) | Synthetic method of ciprofibrate | |
| CN101717346B (en) | Artificial synthesis method of capsaicin homologue | |
| CN102020554A (en) | Synthesis method of 2-[4-(hydroxyphenoxy)] propionic acid | |
| CN102617543A (en) | Synthesis methods for piperonyl ethanol and derivatives thereof | |
| CN102875340A (en) | Sarpogrelate intermediate and preparation method thereof | |
| CN105085168A (en) | Sitodiplosis mosellana Gehin sex pheromone precursor and sitodiplosis mosellana Gehin sex pheromone | |
| CN118290435B (en) | Synthesis method of optical purity glabridin | |
| CN102030707A (en) | Method for preparing Blonanserin intermediate | |
| CN103172499B (en) | Oxyresveratrol synthesis method | |
| CN102180773A (en) | Method for preparing resveratrol | |
| CN103396304B (en) | Nervonic acid chemosynthesis method | |
| CN101555205B (en) | Preparing method of 3-oxo-1-cyclobutane-carboxylic acid | |
| CN104909994A (en) | Method for synthesizing ciprofibrate intermediate and the intermediate | |
| CN101962320A (en) | Method for preparing intermediate 1,2-dicarboxylicacid of antidiabetic medicine gliclazide | |
| CN102675092A (en) | Method for preparing 2-aryl-2,2-dimethyl methyl acetate | |
| CN103467458A (en) | Preparation methods for rosuvastatin calcium and intermediates thereof | |
| CN101775029A (en) | Convenient synthesis method for alkyl substitution phenyloboricacid |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20140326 |

